Strides Pharma stock: The share subscription agreements are being executed at a pre-money equity value of $1.65 billion, delivering to shareholders an embedded value of Rs 663 per share of Strides’ holding in OneSource.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.